Page 45 - Sohini Das

Corporates relook at work-from-home policy as Covid cases resurge

India reports a single-day spike of 702 cases; 6 deaths

Few shares of Keshub, Sudha Mahindra in PMSL transferred to family members

The transmission disclosed herein involves a change in the shareholding/voting rights of PMSL as a result of the transmission of certain shares of PMSL, and does not pertain to shares of M&M directly

Biological E develops next gen XBB1.5 variant Covid vax, awaits clearance

XBB 1.5 is a sub-variant of Omicron, and a sub-linear of XBB variant. It is a recombinant of the two BA.2 sublineages, and carries a mutation of the spike protein (F486P)

Covid-19 back this winter but vaccine makers have limited stockpiles

Gennova has 1 mn doses of Omicron-specific vax; Serum's Covovax available at vaccination centres, shows CoWIN

Trade generics growth to dent value expansion of domestic drug market

Jan Aushadhi and trade generics together constitute 20-22% of pharma market volumes

States gear up as Covid surges: Big hospitals ready, smaller ones concerned

States have started issuing fresh guidelines as cases continue to rise

Shot stories: Meet Bharat Biotech's Krishna Ella, the man behind Covaxin

As the pandemic raged, India developed its own vaccine. Those weren't easy days, Ella, the man behind Covaxin, tells Sohini Das

We have developed an 80% biodegradable tyre: JK Tyre CMD Singhania

Average selling price of tyres will 'slightly move up', he says in interview about where industry is headed

OEM, dealers to play Santa during year-end for EV passenger vehicles

Carmakers, dealers offering discounts up to Rs 4 lakh

Up & down the job rollercoaster: Highs for aviation & pharma, lows for IT

The game flipped in the second half of 2022, and in 2023, it has decisively turned in the favour of employers - more talent is now chasing fewer active IT jobs

JB Chemicals buys opthalmology brands from Novartis for Rs 964 crore

JB Chemicals and Pharmaceuticals shall offer employment to the impacted associates working on this portfolio, it said today. JB Chemicals shares ended on BSE at Rs 1466 apiece, down marginally

Why Maruti remains big on small cars, even when India shifts to larger cars

MSIL, the quintessential maker of small cars, has not fallen short of taking a bet on small hatchbacks even when there seems to be a structural shift in the Indian market towards larger cars

India on alert as JN.1 Covid variant emerges, active cases surge to 1,828

MoH issues advisories to states. Karnataka brings back mask rule for senior citizens after Kerala sees spike in cases

Zydus Noveltech dissolved for not generating 'meaningful revenue'

It had nil operating revenue and a net worth of Rs 10 crore as of March 31, 2023

Kerala reports 4 Covid deaths as cases spike, MoHFW conducts mock drill

Nothing to worry about, says state health minister

Hospitals see 7-8% surge in patient footfall, new investments in 2023

Jose told Business Standard that investments in medical equipment and increasing bed capacities have picked up in 2023 after a hiatus during the Covid19 period

PharmEasy bags Rs 1.3K cr from Pai; Rs 3.5K cr rights issue oversubscribed

Besides Pai's commitment, PharmEasy raised the remaining Rs 2,200 crore from existing shareholders

Investing half a billion dollar in our generics business: Biocon MD & CEO

Debt-reduction plans are progressing a tad slowly, said Siddharth Mittal

Indian companies likely to garner up to 50% USFDA nod share in 2023

Companies may get up to 375 ANDA approvals in 2023, more than last year's 355

M&M, investors to put Rs 875 cr in Classic Legends over next 2-3 years

CLPL revived heritage brands like Yezdi and Jawa. However, it has been able to gain significant market share in the premium segment, which is still largely dominated by Eicher Motors' Royal Enfield